Prometheus Biosciences CEO Mark McKenna's 2021 pay jumps 314% to $12M
Prometheus Biosciences reports 2021 executive compensation
By ExecPay News
Published: April 1, 2022
Prometheus Biosciences reported fiscal year 2021 executive compensation information on April 1, 2022.
In 2021, four executives at Prometheus Biosciences received on average a compensation package of $6M, a 280% increase compared to previous year.
Average pay of disclosed executives at Prometheus Biosciences
Mark C. McKenna, Chief Executive Officer, received $12M in total, which increased by 314% compared to 2020. 82% of McKenna's compensation, or $9.8M, was in option awards. McKenna also received $1M in bonus, $633K in non-equity incentive plan, $566K in salary, as well as $18K in other compensation.
Allison Luo, Chief Medical Officer, received a compensation package of $4.2M, which increased by 305% compared to previous year. 80% of the compensation package, or $3.4M, was in option awards.
Keith W. Marshall, Chief Financial Officer, earned $4.1M in 2021, a 438% increase compared to previous year.
Mark Stenhouse, Chief Operating Officer, received $3.5M in 2021.
Related executives
You may also like
Source: SEC filing on April 1, 2022.